RLS-0071

ReAlta Life Sciences doses first patient in trial of graft-versus-host disease drug
Clinical Trials Arena
Tue, 09/24/24 - 09:56 pm
ReAlta Life Sciences
RLS-0071
graft vs host disease
clinical trials